Concepedia

Author

Maria Pagano

Istituti di Ricovero e Cura a Carattere ScientificoORCID

Also Known As

M Pagano, M. Pagano, MARIA TERESA PAGANO, Maria Pagano, Maria Teresa Pagano, Pagano M

87

Publications

1.5K

Citations

21

H-Index

80

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere ScientificoAzienda Sanitaria Unità Locale di Reggio EmiliaUniversity of ParmaIstituto Superiore di SanitàFondazione IRCCS Istituto Nazionale dei Tumori
MP

About

Maria Pagano is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

19

609

2

Health Sciences

3

3

141

3

Engineering

1

1

33

4

Public Health

1

1

21

5

Allergy

1

1

14

Maria Pagano

×

32

Publications

1.1K

Citations

18

H-Index

YearCitations

Circulating hematopoietic progenitor cells in runners

Maria R. Bonsignore, Alessandra Santoro, Maria Pagano,

Journal of Applied Physiology

2002

123

Prognostic and Predictive Value of Baseline and Posttreatment Molecular Marker Expression in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy

Federica Bertolini, Carmelo Bengala, Luisa Losi,

International Journal of Radiation Oncology*Biology*Physics

2007

106

Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial

Carmine Pinto, Paolo Andrea Zucali, Maria Pagano,

The Lancet Oncology

2021

98

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial

Quincy S. Chu, Laurent Greillier, Wei Tu,

The Lancet

2023

86

Defining the Time of Fetal or Perinatal Acquisition of Human Immunodeficiency Virus Type 1 Infection on the Basis of Age at First Positive Culture

Leslie A. Kalish, Jane Pitt, Judy Lew,

The Journal of Infectious Diseases

1997

73

Sunitinib, Pazopanib or Sorafenib for the Treatment of Patients with Late Relapsing Metastatic Renal Cell Carcinoma

Matteo Santoni, Alessandro Conti, Camillo Porta,

The Journal of Urology

2014

60

The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis

Maria Luisa Dupuis, Fabrizio Conti, Angela Maselli,

Frontiers in Immunology

2018

60

Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey

Cristina Masini, Roberto Sabbatini, Camillo Porta,

British Journal of Urology

2012

44

Vitamin D and Sex Differences in COVID-19

Maria Pagano, Daniela Peruzzu, Anna Ruggieri,

Frontiers in Endocrinology

2020

36

Therapeutic activity of testosterone in metastatic breast cancer.

C. Boni, Maria Pagano, Michele Panebianco,

PubMed

2014

34

Page 1